Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal Plus vs Biphasic Insulin in T2DM (B to B)
NCT01212913Phase 4Completed
- Sponsor
- Sanofi
- Start
- Aug 2010
- Primary completion
- May 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Aug 2010; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01212913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01212913.